THJ-2201 acts as a full agonist with a binding affinity of 1.34nM at CB and 1.32nM at CB cannabinoid receptors.
the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.
It is a drug which acts as a potent but unselective agonist for the cannabinoid receptor CB1 or CB2.
AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively.
The physiological actions and metabolism of AM2201 have not been characterized.
This product is a qualified Reference Material (RM)
that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines.
These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements.